Al-enabled-Cell-Culture-Media-Development-Platform-3

Al-enabled Cell Culture Media Development Platform

Introduction

AlfaMedX® is a cell culture media development platform independently developed by Great Bay Bio. By using AI algorithms, such as machine deep learning and transfer learning, AlfaMedX® builds media formulations on prediction model, and develops customized media for mammalian cell culture, stem cell culture and cultivated meat etc., substantially reducing development time and cost.

Powerful AI Algorithm

Cell Culture Media Development

tech-2 (1)

Improved cell line growth kinetics, and the protein expression improves by more than 30% compared to commercial media.

tech-2 (1)

Good protein quality such as glycan profile, charge heterogeneity, etc.

tech-2 (1)

High stability and easy to store.

tech-2 (1)

Simple composition and and quality assurance.

Why Choose AlfaMedX® Platform?

tech-2-8

Rapid adaptation to catalog culture media

3000+ Cell culture media formulation
AI 
Recommandation
3-5 
Tests to obtain superior media

tech-2-9

Rapid optimization of culture media

50%-200% increased antibody expression
From 5 g/L to 10 g/LCHO K1 protein expression
From 7.8 g/L to 10 g/LCHO GS protein expression

Strategic Partnership Models

tech-2-10

Culture media supply service
GBB provides liquid and powdered culture media to customers, including growth media, feed media, perfusion culture media, stem cell growth culture media, differentiation culture media, cultured meat production media, etc.

tech-2-11

Culture media formulation development service
GBB provides customized development service for CHO cells, muscle stem cells, adipose stem cells, etc.

tech-2-12

Culture media formulation transfer service
GBB provides customized culture media formulations and transfer formulations to customers.

tech-2-13

Strategic cooperation
GBB establishes strategic cooperation with domestic and foreign culture media companies to jointly promote the culture media business.

Al-enabled Cell Culture Media Development Platform-2

Interested In Our Technology Platforms?

Let's Partner up